🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jake R. Morgan

Boston University

ORCID: 0000-0002-1559-3983

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.210Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019

Health Services Research(2023)10.1111/1475-6773.14200

Top 63%

0.210DataRank

Top 63%3 citations

Shapei Yan, Audrey M. Lambert, Jake R. Morgan, Traci C. Green, Philip J. Jeng +7 more

Papers

Driven by 14 papers — median percentile 37. Top paper: “Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting”.

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.29676

N/A

1.3DataRank · unranked

38 citations

Joshua A. Barocas, Sean M. Murphy, Rachel Epstein, Michael D. Stein, Bruce R. Schackman +3 more

Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths

Journal of Addiction Medicine(2023)10.1097/adm.0000000000001218

N/A

0.241DataRank · unranked

4 citations

Mathieu Castry, Rachel Bowers-Sword, Shruti Shantharam, Arnie Aldridge, Gary A. Zarkin +5 more

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019

Health Services Research(2023)10.1111/1475-6773.14200

Top 63%

0.210DataRank

Top 63%3 citations

Shapei Yan, Audrey M. Lambert, Jake R. Morgan, Traci C. Green, Philip J. Jeng +7 more

Commentary on Karnik et al.: Harmonization now—the need for consistent, validated measures to identify opioid use disorder in observational data

Addiction(2022)10.1111/add.15977

N/A

0DataRank · unranked

8 citations

Marc R. Larochelle, Jake R. Morgan

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.29583

N/A

0DataRank · unranked

20 citations

Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R. Schackman, Jianing Wang +8 more

The limits of innovation: Directly addressing known challenges is necessary to improve the real‐world experience of novel medications for opioid use disorder

Academic Emergency Medicine(2023)10.1111/acem.14814

N/A

0DataRank · unranked

7 citations

Sabrina A. Assoumou, Jake R. Morgan

The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States

Journal of the American Pharmacists Association(2024)10.1016/j.japh.2024.102093

N/A

0DataRank · unranked

3 citations

Ali Jalali, Sean M. Murphy, Alexander Y. Walley, Benjamin P. Linas, Philip J. Jeng +6 more

Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits

JAMA Health Forum(2024)10.1001/jamahealthforum.2024.4216

N/A

0DataRank · unranked

2 citations

Alvin D. Jeffery, Manuel Horta, Yixuan Li, Sarah S. Osmundson, Julia C. Phillippi +4 more

Medications for Opioid Use Disorder in County Jails — Outcomes after Release

New England Journal of Medicine(2025)10.1056/nejmsa2415987

N/A

0DataRank · unranked

10 citations

Donna Wilson, Thomas J. Stopka, Dana Bernson, Ekaterina Pivovarova, Warren J. Ferguson +9 more

A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2025.112783

N/A

0DataRank · unranked

3 citations

Leah C. Shaw, Xiao Zang, Bruce R. Schackman, Alexander Y. Walley, Catherine Urquhart +5 more

Outcomes Associated With Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis

Clinical Infectious Diseases(2020)10.1093/cid/ciaa062

N/A

0DataRank · unranked

63 citations

Jake R. Morgan, Jianing Wang, Dylan McLoone, Alysse G. Wurcel, Michael D. Stein +1 more

Care management staff perspectives on stigma and barriers to substance use treatment experienced by latine adults who use substances

Drug and Alcohol Dependence Reports(2025)10.1016/j.dadr.2025.100342

N/A

0DataRank · unranked

0 citations

Erika G. Cordova-Ramos, Damaris J. Rohsenow, Kim T. Mueser, Christine A. Pace, Rosemarie A. Martin +7 more

Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.108764

N/A

0DataRank · unranked

63 citations

Alexander Y. Walley, Sean M. Murphy, Avik Chatterjee, Scott E. Hadland, Joshua A. Barocas +3 more

Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured

American Journal of Preventive Medicine(2022)10.1016/j.amepre.2022.03.010

N/A

0DataRank · unranked

6 citations

Jianing Wang, Laura F. White, Shashi N. Kapadia, Jake R. Morgan, Yuhua Bao +2 more